Literature DB >> 15262668

Allergic to generics.

Troyen A Brennan1, Thomas H Lee.   

Abstract

A 69-year-old woman with several medical problems believes that she is allergic to generic medications. She frequently conflicts with her long-time primary care physician, who, as required by the patient's insurance coverage, refuses to prescribe brand-name drugs when generic alternatives are available. This conflict intensifies to a crisis when the patient develops life-threatening problems and still will not take prescribed generic medications. The presentation of this real case is accompanied by a discussion of the ethical dilemmas of the patient's physician, who must weigh the interests of a patient who clings to beliefs that the physician thinks are unfounded against the interests of a just rationing program and the broader population it serves.

Entities:  

Keywords:  Health Care and Public Health; Professional Patient Relationship

Mesh:

Substances:

Year:  2004        PMID: 15262668     DOI: 10.7326/0003-4819-141-2-200407200-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  10 in total

1.  Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.

Authors:  Richard A Hansen; Jingjing Qian; Richard Berg; James Linneman; Enrique Seoane-Vazquez; Sarah K Dutcher; Saeid Raofi; C David Page; Peggy Peissig
Journal:  Pharmacotherapy       Date:  2017-03-20       Impact factor: 4.705

2.  Comparison of Outcomes Following a Switch From a Brand to an Authorized Versus Independent Generic Drug.

Authors:  R A Hansen; J Qian; R L Berg; J G Linneman; E Seoane-Vazquez; S Dutcher; S Raofi; C D Page; P L Peissig
Journal:  Clin Pharmacol Ther       Date:  2017-10-10       Impact factor: 6.875

3.  Patients' perceptions of generic medications.

Authors:  William H Shrank; Emily R Cox; Michael A Fischer; Jyotsna Mehta; Niteesh K Choudhry
Journal:  Health Aff (Millwood)       Date:  2009 Mar-Apr       Impact factor: 6.301

4.  Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs.

Authors:  Ning Cheng; Md Motiur Rahman; Yasser Alatawi; Jingjing Qian; Peggy L Peissig; Richard L Berg; C David Page; Richard A Hansen
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

5.  Health systems and sustainability: doctors and consumers differ on threats and solutions.

Authors:  Jane Robertson; Emily J Walkom; David A Henry
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

6.  Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors.

Authors:  Ira B Wilson; Cathy Schoen; Patricia Neuman; Michelle Kitchman Strollo; William H Rogers; Hong Chang; Dana Gelb Safran
Journal:  J Gen Intern Med       Date:  2007-01-05       Impact factor: 5.128

7.  Brand name and generic proton pump inhibitor prescriptions in the United States: insights from the national ambulatory medical care survey (2006-2010).

Authors:  Andrew J Gawron; Joseph Feinglass; John E Pandolfino; Bruce K Tan; Michiel J Bove; Stephanie Shintani-Smith
Journal:  Gastroenterol Res Pract       Date:  2015-02-05       Impact factor: 2.260

8.  Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.

Authors:  Rishi J Desai; Ameet Sarpatwari; Sara Dejene; Nazleen F Khan; Joyce Lii; James R Rogers; Sarah K Dutcher; Saeid Raofi; Justin Bohn; John G Connolly; Michael A Fischer; Aaron S Kesselheim; Joshua J Gagne
Journal:  PLoS Med       Date:  2019-03-13       Impact factor: 11.069

9.  Patient Perceptions of Switching to a Generic Dry Powder Inhaler - Increased Understanding Through Journey Mapping.

Authors:  Sarah E Ray; Vanessa Boudewyns; Christine Davis; Janice P Tzeng; Ila Srivastava; Oluwamurewa Oguntimein; Denise S Conti; Karen B Feibus
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-08-06

10.  Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.

Authors:  Rishi J Desai; Ameet Sarpatwari; Sara Dejene; Nazleen F Khan; Joyce Lii; James R Rogers; Sarah K Dutcher; Saeid Raofi; Justin Bohn; John Connolly; Michael A Fischer; Aaron S Kesselheim; Joshua J Gagne
Journal:  BMJ       Date:  2018-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.